bmi needed for glp 1 Achieve Safe & Successful Weight Loss with GLP-1 BMI Guidelines for Tirzepatide Eligibility
Description
Improvement of Lipid and Glucose Metabolism Disorders 4.1.1
Press Release, US FDA, Jun 4, 2021
PMID: 28 GersteinHCColhounHMDagenaisGRDiazRLakshmananMPaisPet al
Microdosing GLP-1 for autoimmune conditions is an emerging area of interest, with some practitioners maintaining patients on very low doses primarily for anti-inflammatory benefits rather than weight management
Yeast infections, particularly vulvovaginal candidiasis and candidal balanitis, are not listed as recognized adverse effects specific to these medications in clinical trials or post-marketing surveillance data
10.1016/s0168-8227(02)00130-4 21 ChaiteerakijR.PetersenG
